Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

Patients with follicular lymphoma (FL) frequently require multiple treatments during their disease course; however, survival based on lines of treatment remains poorly described in the post-rituximab era. Also, the Follicular Lymphoma International Prognostic Index (FLIPI) score was developed to pre...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Blood Cancer J
Main Authors: Batlevi, Connie L., Sha, Fushen, Alperovich, Anna, Ni, Ai, Smith, Katy, Ying, Zhitao, Soumerai, Jacob D., Caron, Philip C., Falchi, Lorenzo, Hamilton, Audrey, Hamlin, Paul A., Horwitz, Steven M., Joffe, Erel, Kumar, Anita, Matasar, Matthew J., Moskowitz, Alison J., Moskowitz, Craig H., Noy, Ariela, Owens, Colette, Palomba, Lia M., Straus, David, von Keudell, Gottfried, Zelenetz, Andrew D., Seshan, Venkatraman E., Younes, Anas
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7366724/
https://ncbi.nlm.nih.gov/pubmed/32678074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-020-00340-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares